What types of genomic alterations can comprehensive genomic profiling detect?

CGP can detect various genetic alterations, including mutations, copy number variations, and structural variations such as gene fusions. This broad analysis enhances the understanding of cancer biology and informs treatment strategies.

How does comprehensive genomic profiling influence the cost of drug development?

While initial investments in CGP may seem high, the potential to streamline drug discovery, improve patient outcomes, and reduce trial failures can ultimately lead to significant cost savings throughout the development process.

Is comprehensive genomic profiling applicable to all therapeutic areas?

While particularly impactful in oncology, CGP is increasingly being utilized across various therapeutic areas, including neurology, immunology, and rare diseases, contributing to advancements in precision medicine.